Introduction
Since Huggins' seminal discovery showing that growth of the prostate gland depends on male sex hormones, androgen deprivation therapy has been the gold standard for the treatment of advanced prostate cancer (CaP) (Huggins and Hodges, 1941) . However, the vast majority of the patients eventually relapse after a period of initial response to hormone therapy. Molecular mechanisms involved in the cell proliferation and differentiation of the prostate by androgen, as well as androgen ablation mediated prostate cell death and emergence of androgen independent cancers are under active investigations (Coffey, 1992; Hakimi et al., 1996; Augustus et al., 1999; Tindall and Scardino, 1999; Grossmann et al., 2001) .
Biologic effects of androgen on target cells, e.g., prostatic epithelial are in part mediated by transcriptional regulation of ARGs by the androgen receptor (AR) (Coffey, 1992; Hakimi et al., 1996; Augustus et al., 1999; Tindall and Scardino, 1999; Grossmann et al., 2001) . Gain of AR functions is believed to play some role in prostate tumorigenesis. Alterations of the AR gene by mutations in the hormone-binding domain have been reported in a subset advanced stage of CaP (Tilley et al., 1996; Grossmann et al., 2001) . Amplifications of the AR gene in hormone refractory CaP represent yet another scenario where gain of AR functions may be associated with tumor progression (Visakorpi et al., 1995) . Germ-line alterations of CAG repeat length in AR may influence the risk of CaP (Hakimi et al., 1996; Hardy et al., 1996; Stanford et al., 1997) . Growth factors commonly involved in cell proliferation and tumorigenesis, e.g., IGF I, EGF and KGF have been shown to activate the transcription transactivation functions of the AR (Culig et al., 1994) . Recent studies analysing expression of ARGs in hormone sensitive and refractory CWR22 nude mice xenograft model have also shown sustained expression of some ARGs in AR positive recurrent tumors following castration suggesting constitutive activation of AR signaling in these tumors (Nagabhushan et al., Amler et al., 2000; Mousses et al., 2002) . Thus androgen regulation of critical target genes may play a role in normal prostate growth and prostate tumorigenesis.
Therefore, systematic and comprehensive analysis of the ARGs should provide the reporters for androgen signaling in CaP. These reporters may serve as potential biomarkers for predisposition/initiation/ progression of prostate cancers (Xu et al., 2001; Vaarala et al., 2000; Amler et al., 2000) . Towards this aim, we are analysing the ARG repertoire in prostate cancer cells using high-throughput approaches and evaluating their significance in human CaP (Xu et al., 2000a (Xu et al., , 2001 . The objective of this study is to define biochemical pathway(s) regulated by androgen signaling by analysing coordinated expression of genes linked to specific pathway(s) and further evaluate the role of such pathway(s) in human prostate tumorigenesis. We have determined the temporal expression profiles of ARGs in widely used hormone responsive LNCaP cells (Horoszewicz et al., 1983) . Our results show coordinated regulation of ARGs in distinct and specific biochemical pathways and this report focuses on our new observations on the coordinated regulation of genes in ER stress response. Further, significantly decreased expression of two selected ER stress responsive genes, NDRG1 and HERPUD1, were noted in cancer cells when laser capture microdissected (LCM) paired normal and cancer cells from prostate cancer patients were analysed. Abrogation of regulation of ER stress responsive genes, e.g., NDRG1 and HERPUD1 may contribute in prostate tumorigenesis.
Results

Androgen regulated gene repertoire as a reporter for probing androgen signaling in LNCaP cells
We analysed the temporal gene expression profiles in LNCaP cells in response to 0.1 nM and 10 nM synthetic androgen R1881 between the 0 -24 h time points. LNCaP cells were chosen for this study, because of consistent androgen responsiveness of this cell line in luciferase-reporter assays, when compared with other AR positive immortalized normal epithelial cells or cancer cells (T Segawa and S Srivastava, unpublished) (Segawa et al., 1998) . Although LNCaP cells harbor mutant ARs these cells are the widely used prostate cancer cell culture model for hormonal regulation until better experimental models are available and validated. When we applied the arbitrary cutoffs of 4threefold induction or 5threefold repression over the control level of expression in at least one of the eight androgen treatment conditions (1, 6, 12, and 24 h for 0.1 and 10 nM R1881 treatments), 241 up-regulated genes and 341 down-regulated genes qualified as potential ARGs (Table 1) . Additional data for ARGs can be obtained from our web site, www.cpdr.org/LNCaP/ GeneChip. As noted in Table 1 , the expression changes of most ARGs were of higher magnitude in 10 nM than in 0.1 nM. Of the known ARGs in the context of prostate, human kallikrein2 (KLK2), Prostate Specific Antigen (PSA or KLK3), and NKX3.1 were among the highly induced genes. Clusterin and PSMA were among the down-regulated genes. These results served to validate the evaluation of ARGs using high-density oligonucleotide array system. The ARG repertoire identified in this study is anticipated to include both direct as well as indirect targets of AR. Understanding of direct and indirect AR targets is critical as both may influence the overall biologic functions of AR. Nonetheless, preliminary attempts were made to sort out direct AR directs using computational and kinetic approaches, which of course will require future experimental validations. Since genes directly regulated by the AR are expected to be more critical in androgen mediated cell signaling, we have evaluated the presence of cisregulatory elements in the 5' promoter regions of ARGs. Consensus DNA sequences to which AR binds (androgen responsive element, ARE), are already characterized. We searched for potential ARE sequences in 5' promoter regions of ARGs (Claessens et al., 2001) . For this purpose, we selected early androgen-induced transcription regulators with the assumption that these were more likely to be direct targets of AR. As in Table 1 , numerous transcription regulators were found among the early-induced ARGs, which may represent early events of AR signaling, that is, AR-Network. Indeed, a number of early-induced ARGs do contain potential ARE sequences in their 5' promoter regions (Table 2) . Further, experimental documentation for potentially new direct AR targets will be needed.
Temporal expression profile in response to androgen treatments of LNCaP cells revealed coordinated expression changes of functionally related genes
Previous results of microarray experiments have shown that genes with coordinated expressions might have a distinct biological function in common (Iyer et al., 1999; Fambrough et al., 1999) . We applied hierarchical clustering methods to group the ARGs solely based on the expression patterns (Eisen et al., 1998) (Figure 1 ). Functional information of the genes was retrieved with the aid of internet-based gene repository databases, GeneCard, UniGene, and OMIM. The analysis was performed in an unbiased manner. Here we identified two biochemical pathways previously shown to be androgen regulated and one novel androgen regulated pathway i.e., ER stress response.
Coordinated regulation of genes involved in fatty acid and cholesterol biosynthesis by androgen Coordinated regulation of expression of genes involved in cholesterol and fatty acid synthesis were identified in response to androgen (Figure 1 ). In agreement with recent reports (Swinnen et al., 1997; Heemers et al., 2001) , many genes involved in fatty acid and cholesterol synthesis: fatty acid synthase (FASN), fatty acid amide hydrolase (FAAH), low density lipoprotein receptor (LDLR), 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR), and farnesyl-diphosphate farnesyltransferase (FDFT1) were all coordinately upregulated in response to 10 nM R1881 and to a lesser extent with 0.1 nM R1881. Up-regulation of these genes is believed to be mediated through androgen dependent activation of SREBPs (Heemers et al., 2001) . In our study androgen also induced expression of SREBP2 as well as SCAP (KIAA0199), which is a chaperone protein, that transports SREBPs from endoplasmic reticulum to Golgi to facilitate the activation of SREBPs. Northern blot and RT -PCR analyses confirmed our GeneChip observations for androgen induction of SREBP2 and SCAP ( Figure  1d,e) . This finding, as well as the presence of ARE-like sequences in the promoter regions of both SCAP and SREBP2, suggest a potentially direct activation of SREBP2-FASN pathway by androgen (Table 2) .
Androgen responsive coordinated regulation of genes associated with polyamine biosynthesis Another expression profile successfully defined by us was coordinated androgen regulation of genes involved in polyamine biosynthesis/metabolism. Although some of these genes were already reported as ARGs, (Fjosne et al., 1990) it is striking to note that all five genes coding for enzymes which regulate polyamine synthesis: ornithine decarboxylase 1 (ODC1), S-adenosylmethio- nine decarboxylase 1 (AMD1), spermine synthase (SMS), spermidine synthase (SRM), and spermidine/ spermine N1-acetyltransferase (SAT) showed very similar expression patterns and therefore clustered with each other (Figure 1 ). On the contrary, ornithine decarboxylase antizyme (OAZ), a key molecule known to negatively regulate the accumulation of polyamines in the cells, did not show any expression changes.
Androgen induction of ER stress response genes ER is optimized for synthesizing, folding, and assembling membrane and soluble proteins destined for secretion or trafficking to lysosomes. Environmental changes leading to the accumulation of unfolded or misfolded proteins in the ER constitute a fundamental threat to the cells and therefore trigger a stress response, referred to as the ER stress response. One aspect of the ER stress response is defined as unfolded protein response (UPR) that shows transcriptional induction of genes encoding ER-resident molecular chaperones and folding enzymes (Mori, 2000) . As shown in Table 1 and Figure  1 many genes having functions of chaperones and folding enzymes are among ARGs. Of note, ORP150, PDIR, HERPUD1 and NDRG1 known to be involved in ER stress responses were induced by androgen (Figure  1d ,e; www.cpdr.org/LNCaP/GeneChip). Oxygen regulated protein 150 kD (ORP150) is an ERresident molecular chaperone, which suppresses hypoxia-induced apoptotic cell death (Ozawa et al., 1999) . Protein disulfide isomerase-related (PDIR) is a stress inducible gene with a thioredoxin-like domain, which acts as a catalyst of protein folding in the lumen of the ER (Kanai et al., 1998) . Besides these typical UPR induced genes, HERPUD1 (KIAA0025), and N-myc downstream regulated gene 1 (NDRG1), which were originally cloned as ER-stress induced genes in HUVEC cells, are also among the ARGs in LNCaP (Kokame et al., 1996) . An earlier report also showed marked upregulation of NDRG1 in response to androgen (Ulrix et al., 1999) . In addition to genes involved in ER stress response, number of stress induced genes were among the ARGs (Figure 1 ). Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA) is a pro-apoptotic gene, which plays a central role in steroid induced anti-inflammation by inactivating NF-kappa-B pathway, which also constitutes a part of ER stress response (Mori, 2000) . Cold shock domain protein A (CSDA) is a member of transcription factors with a cold shock domain, which have been implicated in various cellular processes, including adaptation to low temperatures, and nutrient stress (Graumann and Marahiel, 1998) . Seladin-1 (KIAA0018) is a recently characterized gene whose expression protected neuron cells from apoptosis caused by oxidative stress (Greeve et al., 2000) .
Decreased expressions of ER stress response genes (HERPUD1 and NDRG1) in prostate cancer
To evaluate the modulation of ER stress response genes in CaP, expressions of selected genes (HERPUD1 and NDRG1) were analysed in a test panel of LCM derived paired normal and tumor cells of 20 CaP patients (Figure 2 ). Decreased expressions of two ARGs in this ER stress response pathway correlated very well with malignant status of the prostate. CaP associated decreased expressions of HERPUD1 and NDRG1 were found in 60 and 70% patient specimens respectively. Prostate cancer associated decreased or lack expression of NDRG1 has been described earlier (Kurdistani et al., 1998) , however, cancer associated loss of HERPUD1 has not been reported before.
Discussion
In an attempt to define biochemical pathways regulated by androgen signaling in CaP cells, we have analysed temporal gene expression profiles of ARGs in hormone responsive LNCaP cells using Affymetrix oligonucleotide arrays. A proposed model of the AR transcriptional net work derived from this study and other studies is summarized in Figure 3 . Our study defined consistent androgen dependent expression changes in groups of genes linking to fatty acid and cholesterol synthesis, and polyamine biosynthesis. Gene expression alterations of many genes in these pathways have been previously noted in CaP (Myers et al., 2001; Pizer et al., 2001; Epstein et al., 1995; Mohan et al., 1999; Bettuzzi et al., 2000) . Evaluation of ARG repertoire from LNCaP cells have also led to identification of novel ARGs, e.g., PART1 (Lin et al., 2000) , PSDR1 (Lin et al., 2001 ) and PMEPA1 (Xu et al., 2000a) . Novel observations from this study underscore the androgen modulation of expression of genes in ER stress response and possibly other stress responses. We provide preliminary evidence that two genes involved in ER stress response are downregulated in CaP.
Among the pathways successfully defined in our study was the fatty acid and cholesterol synthesis (Myers et al., 2001; Pizer et al., 2001; Epstein et al., 1995) . According to these reports, FASN expressions were higher in CaP compared to the normal prostate, and served as a predictor for cancer progression (Epstein et al., 1995) . While FASN expression is decreased in the normal prostate upon androgen ablation, cancer specimens from patients undergoing androgen ablation showed elevated expression (Pizer et al., 2001) . We also noted FASN overexpression during androgen independent growth of CWR22 and LNCaP cells, supporting constitutive activation of AR-SREBPs-FASN pathway under androgen withdrawal condition (Myers et al., 2001, Segawa T and Srivastava S, unpublished) .
Polyamine biosynthesis and metabolism pathways are of physiologic significance in the prostate and prostate cancer, because the amounts of polyamines are highest in the prostate among other organs (Crozat et al., 1992 ). An earlier report had identified spermine as an endogeneous inhibitor of prostate carcinoma cell growth (Smith et al., 1995) . Spermine was also shown to induce growth arrest in Dunning rat prostate cancer cell lines (Koike et al., 1999) . In contrast, recent reports have shown positive correlation between CaP progression and the expression of ODC1, AMD, SAT and OAZ (Mohan et al., 1999; Bettuzzi et al., 2000) . Specific ODC1 inhibitor, difluoromethylornithine (DFMO), is being used for chemoprevention or therapeutic trials for CaP (Messing et al., 1999; Simoneau et al., 2001) . Our study emphasizes the androgen regulation of multiple genes in polyamine biosynthesis and metabolism pathways in LNCaP cells. Further studies are warranted to fully understand the role of this pathway in the growth of normal and malignant prostatic epithelial cells.
Androgen modulation of genes involved in the endoplasmic reticulum (ER) stress pathway highlights novel observations of this study. Recently, Travers et al. (2000) have reported genome wide analyses of transcriptional responses to ER stress induced by reducing agent dithiothreitol (DTT) and N-linked glycosylation inhibitor tunicamycin in yeast using the high-density oligonucleotide array technology. Surprisingly, their data revealed that many other aspects of secretory pathway functions were also affected by the UPR (Travers et al., 2000) . These pathways include protein translocation, glycosylation, folding, degradation in ER as well as vesicle trafficking and transport between ER and Golgi to distal secretions. Interestingly, activation of lipid biosynthesis and metabolism seen in our androgen treatment experiments also constitutes a component of UPR under their experimental condition (Travers et al., 2000) . Furthermore, many genes involved in vesicle trafficking and transport such as Rab proteins are indeed found in our ARGs list (Table 1) . Besides the data from LNCaP model, correlation of NDRG1 and HERPUD1 expression with malignant status of the prostate in CaP patients further suggest the involvement of this ER stress pathway in prostate tumorigenesis. NDRG1 is a Figure 3 A proposed model of the AR transcriptional net work based on this study and previous reports. Additional experimental validation of new pathways defined here will be needed member of highly conserved proteins, whose expression is induced by stress responses involving UPR, such as reducing agents, DNA damaging agents and hypoxia (Kokame et al., 2000; Park et al., 2000) . Over expression of NDRG1 in tumor cells decreases the proliferation rate, enhances differentiation, and suppresses the metastatic potency of the cancer cell (Kurdistani et al., 1998; van Belzen et al., 1997; Guan et al., 2000) . Androgen induced expression of NDRG1 may represent a response to stress as well as differentiation signals. Like NDRG1, HERPUD1 is also modulated by ER stress response, however little is known about its function. HERPUD1 is a membrane associated ER protein with a ubiquitin-like domain, with homology to DNA repair protein Rad23A (Ulrix et al., 1999; van Laar et al., 2000) . Its induction was also observed in response to other stresses such as DNA damaging agents and osmotic shocks (Ulrix et al., 1999) .
Although ER stress response appears to be a cellular protective mechanism, there are also studies that suggest mitogenic signals promoting new protein synthesis may also recruit ER stress response proteins (Brewer et al., 1997) . Thus effect of androgen on this pathway may represent a more complex phenomenon. Biologic implications or the mechanisms of androgen induction of stress response genes including ER stress remains to be defined. Androgen induced oxidative stress in LNCaP cells was originally reported by Ripple et al. (1997) and has also been suggested by analysis of ARGs by Xu et al. (2001) . Stress response induced by androgen possibly reflects a protective response to cope with adverse cellular affects of androgens. Linkage of androgen to cellular stress responses may provide molecular explanation for some of the carcinogenic effects of androgen. Androgens are also reported to induce CaP in rat models (Noble, 1977; Pollard, 1998) . Further, men with higher serum androgen show a positive correlation with the risk of CaP (Ross et al., 1986) . Taken together, androgens, in certain biologic setting may unleash carcinogenic/mutagenic properties. Androgen mediated induction of stress responsive genes including ER stress response may reflect protective functions against androgen induced cellular stress. Reduced/loss of expression of such genes in cancer cells may support pro-carcinogenic effects of androgen. Further studies of ARGs involved in stress response pathways may clarify the mechanisms of AR signaling in cellular stress responses including the ER stress response in CaP cells.
Materials and methods
Cell culture and RNA preparation
Androgen dependent prostate cancer cells: LNCaP were obtained from ATCC (Rockville, MD, USA) and maintained in RPMI1640 with 10% fetal bovine serum (FBS, GibcoBRL, Rockville, MD, USA). For the analyses of temporal expression profiles, cells were cultured in RPMI1640 with charcoal/dextran stripped FBS (cFBS, Gemini Bio-Products, Calabasas, CA, USA) for 5 days, and then treated with 0.1 or 10 nM of synthetic androgen R1881 (NEN, Boston, MA, USA). Poly(A) + RNAs were prepared at 0, 1, 6, 12, and 24 h after the treatments with FastTrack RNA preparation kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
Oligonucleotide array analyses
The high-density oligonucleotide array (GeneChip HuGeneFL array; Affymetrix, Santa Clara, CA, USA) represents approximately 5600 human genes/transcripts with some redundancy, roughly one half correspond to known full length genes and the other half correspond to expressed sequence tags (EST) or hypothetical genes. The annotations of genes were regularly updated from EST or hypothetical protein to known genes according to the GeneBank information. Biotin-labeled cRNA was synthesized from 2 microgram of poly(A) + RNA and hybridized to this highdensity oligonucleotide as described previously (Nau et al., 2000) . Briefly, double stranded cDNA was synthesized using Superscript Choice System (GibcoBRL, Rockville, MD, USA) and reverse transcription primer T7-(dT)24 (GENE-SET Corp., LaJolla, CA, USA). Biotin-labeled cRNA was synthesized from the cDNA with biotinylated UTP and CTP (ENZO, Farmingdale, NY, USA) using MEGAscript T7 in vitro Transcription Kit (Ambion, Austin, TX, USA). The biotin-labeled cRNA was purified using RNeasy spin column (Qiagen, Valencia, CA, USA). Biotinylated cRNA was fragmented, assessed by gel electrophoresis, and placed in a hybridization mixture containing four biotinylated hybridization controls. After 16 h hybridization, GeneChips were washed, stained, and then scanned with GeneArray Scanner (Hewlett-Packard, Santa Clara, CA, USA). The images from the scanned chips were processed using Affymetrix GeneChip Analysis Suite 4.0. The image from each GeneChip was scaled such that the average intensity value for all arrays was adjusted to arbitrary value of 2500, to reliably compare variable multiple arrays. Scaled average difference value (SADV) and Absolute Call data from each GeneChip were exported as flat text files and used for further analysis.
Bioinformatics analyses
GeneSpring version 4.0 (Silicon Genetics, San Carlos, CA, USA) and Excel 2000 (Microsoft, Redmond, WA, USA) were used to derive global trends in expression profiles. In the temporal expression comparisons, *3500 genes scored as 'Present' in at least one time point were considered. All the imported SADV were divided by the SADV of control condition (0, no treatment) in GeneSpring software, and factor of fold increase or decrease ('fold changes') was determined. SADV values of 500 or less were set to 500 to avoid division by 0 or a negative number. By GeneSpring software, the 'fold changes' were log transformed and hierarchical clustering was performed on *3500 'Present' genes with Pearson correlation, as initially described by Eisen et al. (1998) .
Information on functions of the genes was retrieved with the aid of internet-based gene repository databases: GeneCard, UniGene, and OMIM, integrated to GeneSpring software (http://bioinformatics.weizmann.ac.il/cards/; http:// www.ncbi.nlm.nih.gov/UniGene/; http://www.ncbi.nlm.nih.gov/ Omim/). The linkage of ARGs to biochemical pathways was evaluated in an unbiased manner without a preconceived notion. On the basis of data obtained, decision was made to follow up on pathway not previously described as androgen regulated. For the prediction of candidate androgen responsive element (ARE) in the promoter regions of ARGs, about 5 kb 5' sequences of ARGs were obtained through public databases, and homologous sequences for consensus ARE, GGTACAnnnTGTTCT, were searched using GeneQuest 4.0 software (Dnastar, Madison, WI, USA).
Northern blot analysis
LNCaP cells were cultured in RPMI1640 with 10% FBS for 5 days and then stimulated with R1881 at 0.1 or 10 nM for 24 h. Total RNA (10 mg/lane) or poly(A) + RNA (1 mg/lane) prepared from these cells was electrophoresed through 1% formaldehyde-agarose gel and transferred to a nylon membrane. cDNA probes of representative ARGs were labeled with 32 P-dCTP, and Northern hybridization was performed as described before (Xu et al., 2000b) .
Prostate tissue specimens and laser capture microdissection (LCM)
Matched prostate cancer and normal glands were derived from radical prostatectomy specimens from prostate cancer patients treated at Walter Reed Army Medical Center (Segawa et al., 1998) . In brief, specimens were obtained by ex vivo sextant biopsy of prostates after radical prostatectomy in the operating room, and Tissue-tek OCT-embedded frozen sections were prepared and archived (Miles Inc, Elkhart, IN, USA). One set of slides was stained with H&E to define tumor cells. The frozen sections on slides were dissected using laser captured microdissection according to the modified protocol of the manufacturer (Arcturus Engineering, Mountain View, CA, USA). Total RNA was isolated using MicroRNA kit (StrataGene, La Jolla, CA, USA) and quantified with VersaFluor fluorimeter (BioRad, Hercules, CA, USA) using RiboGreen (Molecular Probes, Eugene, OR, USA).
Reverse transcription-polymerase chain reaction (RT -PCR) assays
Total RNA (1 nanogram) was reverse transcribed into cDNA with a RT -PCR kit (Perkin-Elmer, Foster, CA, USA) and 1/ 25 of reverse transcribed product was used for PCR to amplify NDRG1, HERPUD1, and a housekeeping gene, GAPDH. The primer sequences for the amplifications were 5'-CTGCACCTGTTCATCAATGCCTAC-3' : 5'-TGCCATC-CAGAGAAGTGACGCTG-3' for NDRG1, and 5'-GAATG-CTGCTCCTCAAGTGGTTG-3' : 5'-CAGTTTCAGGATCA-GTGCCTTCC-3' for HERPUD1. The optimized PCR conditions for amplifying NDRG1 and HERPUD1 were 38 -40 cycles of 948C for 30 s, 608C for 30 s, 728C for 30 s. The expression of GAPDH was used as an internal control for RNA input. Other controls for the RT -PCR assays included PCR amplification of the RNA samples without reverse transcription. The computer-stored images of agarose gels were analysed by densitometry of the bands. Expression was quantified as fold differences in the normalized expression between tumor (T) and normal (N) tissues with a cutoff of twofold difference. Expressions of representative ARGs were analysed with the same method using LNCaP RNAs with or without R1881 10 nM 24 h treatment.
